Digraph
Organize the world
Digraph
Search
Everything
This topic
Blog
Recent
Everything
Sign in
Cefiderocol
Cefiderocol
Fetroja
FETCROJA
Parent topics
New and investigational antibiotics
Siderophore cephalosporins
This topic
Recent activity
You must be
signed in
to add and move topics and links.
2019-11 FDA approves cefiderocol complicated urinary tract infections
Cefiderocol
Complicated urinary tract infections (cUTIs)
United States Food and Drug Administration (FDA)
2020-06 FDA accepts cefiderocol sNDA for priority review
Cefiderocol
United States Food and Drug Administration (FDA)
Cefiderocol Compared With Meropenem for Nosocomial Pneumonia Treatment
https://www.empr.com/home/news/cefiderocol-compared-with-meropenem-for-nosocomial-pneumonia-treatment/
Cefiderocol
Meropenem
Cefiderocol Now Available in the U.S
https://www.idse.net/Bacterial-Infections/Article/02-20/Cefiderocol-Now-Available-in-the-U.S/57395
Cefiderocol
Cefiderocol for Urinary Infections Set for FDA Advisory Review | Medpage Today
https://www.medpagetoday.com/infectiousdisease/generalinfectiousdisease/82754
Cefiderocol
FDA Advisory Committee Backs Cefiderocol Efficacy for cUTI 14-2
https://www.contagionlive.com/news/fda-advisory-committee-backs-cefiderocol-efficacy-for-cuti-142
Cefiderocol
FDA Panel Recommends Cefiderocol for Complicated UTI
https://www.medscape.com/viewarticle/919979
Cefiderocol
FDA Panel Votes on Novel Antibiotic for Complicated UTI - MPR
https://www.empr.com/home/news/fda-panel-votes-on-novel-antibiotic-for-complicated-uti/
Cefiderocol
Investigational antibiotic, Cefiderocol, receives U.S. FDA Advisory Committee recommendation for approval to treat complicated UTIs - Outbreak News Today
http://outbreaknewstoday.com/investigational-antibiotic-cefiderocol-receives-u-s-fda-advisory-committee-recommendation-for-approval-to-treat-complicated-utis-63891/
Cefiderocol
New Antibiotic Proves Mettle in Nosocomial Pneumonia | Medpage Today
https://www.medpagetoday.com/meetingcoverage/idweek/82591
Beta-lactamases
Cefiderocol
Meropenem
New Antibiotics Treat Select Resistant Infections
https://www.pharmacytimes.com/publications/health-system-edition/2020/May2020/new-antibiotics-treat-select-resistant-infections
Cefiderocol
Positive CHMP opinion for Shionogi's treatment of infections due to aerobic Gram-negative bacteria - Pharmafield
https://pharmafield.co.uk/pharma_news/positive-chmp-opinion-for-shionogis-treatment-of-infections-due-to-aerobic-gram-negative-bacteria/
Cefiderocol
Shionogi Announces Data Demonstrating Potent in Vitro Activity of Cefiderocol against the Most Critical Priority Gram-Negative Bacterial Pathogens - DutchNews.nl
https://www.dutchnews.nl/news/businesswire/shionogi-announces-data-demonstrating-potent-in-vitro-activity-of-cefiderocol-against-the-most-critical-priority-gram-negative-bacterial-pathogens/
Antibiotic resistance and the development of new drugs
Cefiderocol
Shionogi Announces Data Demonstrating Potent in Vitro Activity of Cefiderocol against the Most Critical Priority Gram-Negative Bacterial Pathogens | Business Wire
https://www.businesswire.com/news/home/20190414005009/en/Shionogi-Announces-Data-Demonstrating-Potent-Vitro-Activity
Antibiotic resistance and the development of new drugs
Cefiderocol
Shionogi announces data demonstrating potent in vitro activity of cefiderocol against the most critical priority gram-negative bacterial pathogens - PharmiWeb.com
https://www.pharmiweb.com/press-release/2019-04-17/shionogi-announces-data-demonstrating-potent-in-vitro-activity-of-cefiderocol-against-the-most-critical-priority-gram-negative-bacterial-pathogens
Antibiotic resistance and the development of new drugs
Cefiderocol
Shionogi to Present Cefiderocol and COT-143 Data at American Society for Microbiology Microbe 2019 Meeting
https://finance.yahoo.com/news/shionogi-present-cefiderocol-cot-143-143500692.html
Cefiderocol
Pharmaceutical makers, antibiotic resistance and the development of new drugs
Stewardship / Resistance Scan for Feb 25, 2020 | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2020/02/stewardship-resistance-scan-feb-25-2020
Cefiderocol
PLG0206
Peptide antibiotics
Stewardship / Resistance Scan for Oct 03, 2019 | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/10/stewardship-resistance-scan-oct-03-2019
Cefiderocol
Stewardship / Resistance Scan for Oct 07, 2019 | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/10/stewardship-resistance-scan-oct-07-2019
Aminoglycosides
Carbapenems
Cefiderocol
Chloramphenicol
Colistin
Extensively drug-resistant (XDR) Klebsiella pneumoniae
Fosfomycin
Quinolones
Tigecycline
Stewardship / Resistance Scan for Oct 17, 2019 | CIDRAP
http://www.cidrap.umn.edu/news-perspective/2019/10/stewardship-resistance-scan-oct-17-2019
Cefiderocol
Two More Agents Bolster the Arsenal Against Gram-Negative Resistance
https://www.contagionlive.com/publications/contagion/2019/december/two-more-agents-bolster-the-arsenal-against-gramnegative-resistance
Cefiderocol
Imipenem-cilastatin-relebactam
U.S. FDA Advisory Committee Recommends Approval of Cefiderocol for Treatment of Complicated Urinary Tract Infections | Business Wire
https://www.businesswire.com/news/home/20191016005916/en/U.S.-FDA-Advisory-Committee-Recommends-Approval-Cefiderocol
Cefiderocol
What's New From the CLSI Subcommittee on Antimicrobial Susceptibility Testing
https://www.contagionlive.com/publications/contagion/2019/october/whats-new-from-the-clsi-subcommittee-on-antimicrobial-susceptibility-testing
Azithromycin
CLSI Subcommittee on Antimicrobial Susceptibility Testing (AST)
Cefiderocol
Ceftazidime-avibactam
Ceftriaxone
Colistin
Daptomycin
Enterococcus faecalis
Enterococcus faecium
Meropenem-vaborbactam
Plazomicin
Polymyxin B
Polymyxins
With Potent In Vitro Activity, Cefiderocol a Promising Option for Treating Resistance
https://www.contagionlive.com/news/with-potent-in-vitro-activity-cefiderocol-a-promising-option-for-treating-resistance
Antibiotic resistance and the development of new drugs
Cefiderocol
[Full text] Designing A Pathogen-Focused Study To Address The High Unmet Medical N | IDR
https://www.dovepress.com/designing-a-pathogen-focused-study-to-address-the-high-unmet-medical-n-peer-reviewed-fulltext-article-IDR
Carbapenem-resistant Enterobacteriaceae (CRE)
Cefiderocol